Literature DB >> 17533519

The role of paraoxonase (PON) enzyme in the extent and severity of the coronary artery disease in type-2 diabetic patients.

Zeynep Tartan1, Gokcen Orhan, Hulya Kasikçioglu, Huseyin Uyarel, Sennur Unal, Nihat Ozer, Batuhan Ozay, Figen Ciloglu, Nese Cam.   

Abstract

Increased coronary artery disease (CAD) risk is well established in diabetes mellitus (DM). Paraoxonase (PON) enzyme is known to have protective effects on lipid peroxidation. This study aimed to investigate the changes in PON activity levels with duration of DM as well as the role of PON activity in progression of CAD. Eighty-four consecutive diabetic patients (mean age 58 years, 46 men) who underwent coronary angiography for diagnostic purposes were examined. Before the angiography, fasting venous blood samples were taken for PON enzyme activity, thiobarbituric acid reactive substances (TBARS), and routine biochemical parameters. Severity and extent of coronary atherosclerosis were scored numerically using the Gensini scoring system. The population was divided into three groups according to Gensini score: Group 1, mild CAD; Group 2, moderate CAD; Group 3, severe CAD. Group 1 had higher PON levels and shorter DM duration than those of Group 3. Gensini score was significantly correlated with, PON activity (r = -0.361) and apo-AI (r = -0.375). TBARS (r = -0.290) and the duration of DM (r = -0.336) also showed a significant correlation with PON activity levels. Also, multivariate linear regression and Pearson correlation analyses showed that PON activity (P = 0.04), apo-AI levels (P = 0.01), and the duration of DM (P = 0.003) were significantly associated with Gensini score. Paraoxonase activity decreases parallel to DM duration. The lack of protective effect of PON enzyme on lipid peroxidation may be a factor in acceleration of CAD in DM.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17533519     DOI: 10.1007/s00380-006-0957-6

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  34 in total

1.  Four paraoxonase gene polymorphisms in 11212 cases of coronary heart disease and 12786 controls: meta-analysis of 43 studies.

Authors:  Jeremy G Wheeler; Bernard D Keavney; Hugh Watkins; Rory Collins; John Danesh
Journal:  Lancet       Date:  2004-02-28       Impact factor: 79.321

2.  Introduction to the serial review on paraoxonases, oxidative stress, and cardiovascular diseases.

Authors:  Michael Aviram
Journal:  Free Radic Biol Med       Date:  2004-11-01       Impact factor: 7.376

3.  Defective antioxidative activity of small dense HDL3 particles in type 2 diabetes: relationship to elevated oxidative stress and hyperglycaemia.

Authors:  E Nobécourt; S Jacqueminet; B Hansel; S Chantepie; A Grimaldi; M J Chapman; A Kontush
Journal:  Diabetologia       Date:  2005-02-24       Impact factor: 10.122

4.  Human serum Paraoxonase/Arylesterase's retained hydrophobic N-terminal leader sequence associates with HDLs by binding phospholipids : apolipoprotein A-I stabilizes activity.

Authors:  R C Sorenson; C L Bisgaier; M Aviram; C Hsu; S Billecke; B N La Du
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-09       Impact factor: 8.311

5.  Glycation impairs high-density lipoprotein function.

Authors:  C C Hedrick; S R Thorpe; M X Fu; C M Harper; J Yoo; S M Kim; H Wong; A L Peters
Journal:  Diabetologia       Date:  2000-03       Impact factor: 10.122

6.  Cellular antioxidant effects of atorvastatin in vitro and in vivo.

Authors:  Sven Wassmann; Ulrich Laufs; Kirsten Müller; Christian Konkol; Katja Ahlbory; Anselm T Bäumer; Wolfgang Linz; Michael Böhm; Georg Nickenig
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-02-01       Impact factor: 8.311

Review 7.  Diabetes mellitus and cardiovascular disease in women.

Authors:  J R Sowers
Journal:  Arch Intern Med       Date:  1998-03-23

8.  Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation.

Authors:  K G Alberti; P Z Zimmet
Journal:  Diabet Med       Date:  1998-07       Impact factor: 4.359

9.  Atorvastatin therapy in hypercholesterolemic patients suppresses cellular uptake of oxidized-LDL by differentiating monocytes.

Authors:  Bianca Fuhrman; Lena Koren; Nina Volkova; Shlomo Keidar; Tony Hayek; Michael Aviram
Journal:  Atherosclerosis       Date:  2002-09       Impact factor: 5.162

10.  Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase.

Authors:  M I Mackness; S Arrol; C Abbott; P N Durrington
Journal:  Atherosclerosis       Date:  1993-12       Impact factor: 5.162

View more
  8 in total

Review 1.  Paraoxonase 1, atherosclerosis and arterial stiffness in renal patients.

Authors:  Ozkan Gungor; Fatih Kircelli; Huseyin Toz
Journal:  Int Urol Nephrol       Date:  2012-06-06       Impact factor: 2.370

2.  The effect of grape seed extracts on serum paraoxonase activities in streptozotocin-induced diabetic rats.

Authors:  Aysel Kiyici; Nilsel Okudan; Hakki Gökbel; Muaz Belviranli
Journal:  J Med Food       Date:  2010-06       Impact factor: 2.786

3.  Smoking is associated with reduced serum paraoxonase, antioxidants and increased oxidative stress in normolipidaemic acute myocardial infarct patients.

Authors:  Arun Kumar; Utpal Kumar Biswas
Journal:  Heart Asia       Date:  2011-01-01

4.  Synergistic effects between 561A > C and 98G > T polymorphisms of E-selectin gene and hypercholesterolemia in determining the susceptibility to coronary artery disease.

Authors:  Iwona Zak; Beata Sarecka; Jolanta Krauze
Journal:  Heart Vessels       Date:  2008-07-23       Impact factor: 2.037

5.  Paraoxonase (PON1) activity in patients with subclinical thoracic aortic atherosclerosis.

Authors:  Mustafa Gür; Murat Çaylı; Hakan Uçar; Zafer Elbasan; Durmuş Yıldıray Şahin; Mehmet Yavuz Gözükara; Şahbettin Selek; Nermin Yıldız Koyunsever; Taner Şeker; Caner Türkoğlu; Onur Kaypaklı; Nurten Aksoy
Journal:  Int J Cardiovasc Imaging       Date:  2014-04-04       Impact factor: 2.357

6.  The effects of type 2 diabetes on lipoprotein composition and arterial stiffness in male youth.

Authors:  Scott M Gordon; W Sean Davidson; Elaine M Urbina; Lawrence M Dolan; Anna Heink; Huaiyu Zang; L Jason Lu; Amy S Shah
Journal:  Diabetes       Date:  2013-07-08       Impact factor: 9.461

7.  Using a Targeted Proteomics Chip to Explore Pathophysiological Pathways for Incident Diabetes- The Malmö Preventive Project.

Authors:  John Molvin; Manan Pareek; Amra Jujic; Olle Melander; Lennart Råstam; Ulf Lindblad; Bledar Daka; Margrét Leósdóttir; Peter M Nilsson; Michael H Olsen; Martin Magnusson
Journal:  Sci Rep       Date:  2019-01-22       Impact factor: 4.379

8.  Reduced paraoxonase 1 activity as a marker for severe coronary artery disease.

Authors:  Chiyan Zhou; Jia Cao; Liang Shang; Chuanfeng Tong; Hanling Hu; Hui Wang; Daping Fan; Hong Yu
Journal:  Dis Markers       Date:  2013-07-28       Impact factor: 3.434

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.